These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

435 related items for PubMed ID: 19840554

  • 1. Innate and adaptive autoimmunity directed to the central nervous system.
    Bhat R, Steinman L.
    Neuron; 2009 Oct 15; 64(1):123-32. PubMed ID: 19840554
    [Abstract] [Full Text] [Related]

  • 2. The role of innate immune responses in autoimmune disease development.
    Waldner H.
    Autoimmun Rev; 2009 Mar 15; 8(5):400-4. PubMed ID: 19162250
    [Abstract] [Full Text] [Related]

  • 3. Orchestrating innate immune responses in multiple sclerosis: molecular players.
    Fernández M, Montalban X, Comabella M.
    J Neuroimmunol; 2010 Aug 25; 225(1-2):5-12. PubMed ID: 20537409
    [Abstract] [Full Text] [Related]

  • 4. Taking advantage of the systemic immune system to cure brain diseases.
    Yong VW, Rivest S.
    Neuron; 2009 Oct 15; 64(1):55-60. PubMed ID: 19840549
    [Abstract] [Full Text] [Related]

  • 5. Innate autoimmunity.
    Carroll MC, Holers VM.
    Adv Immunol; 2005 Oct 15; 86():137-57. PubMed ID: 15705421
    [Abstract] [Full Text] [Related]

  • 6. Brain-immune communication psychoneuroimmunology of multiple sclerosis.
    Kern S, Ziemssen T.
    Mult Scler; 2008 Jan 15; 14(1):6-21. PubMed ID: 17881389
    [Abstract] [Full Text] [Related]

  • 7. Autoantibody-mediated disorders of the central nervous system.
    Irani S, Lang B.
    Autoimmunity; 2008 Feb 15; 41(1):55-65. PubMed ID: 18176865
    [Abstract] [Full Text] [Related]

  • 8. Innate immunity and protective neuroinflammation: new emphasis on the role of neuroimmune regulatory proteins.
    Griffiths M, Neal JW, Gasque P.
    Int Rev Neurobiol; 2007 Feb 15; 82():29-55. PubMed ID: 17678954
    [Abstract] [Full Text] [Related]

  • 9. The interplay between the immune and central nervous systems in neuronal injury.
    Yong VW, Marks S.
    Neurology; 2010 Jan 05; 74 Suppl 1():S9-S16. PubMed ID: 20038767
    [Abstract] [Full Text] [Related]

  • 10. Distribution of the immune inhibitory molecules CD200 and CD200R in the normal central nervous system and multiple sclerosis lesions suggests neuron-glia and glia-glia interactions.
    Koning N, Swaab DF, Hoek RM, Huitinga I.
    J Neuropathol Exp Neurol; 2009 Feb 05; 68(2):159-67. PubMed ID: 19151626
    [Abstract] [Full Text] [Related]

  • 11. Role of complement in innate and autoimmunity.
    Seelen MA, Roos A, Daha MR.
    J Nephrol; 2005 Feb 05; 18(6):642-53. PubMed ID: 16358221
    [Abstract] [Full Text] [Related]

  • 12. The role of the innate immune response in autoimmune disease.
    Lang KS, Burow A, Kurrer M, Lang PA, Recher M.
    J Autoimmun; 2007 Dec 05; 29(4):206-12. PubMed ID: 17904335
    [Abstract] [Full Text] [Related]

  • 13. Immune proteins in brain development and synaptic plasticity.
    Boulanger LM.
    Neuron; 2009 Oct 15; 64(1):93-109. PubMed ID: 19840552
    [Abstract] [Full Text] [Related]

  • 14. Toll-like receptors in autoimmunity.
    Fischer M, Ehlers M.
    Ann N Y Acad Sci; 2008 Nov 15; 1143():21-34. PubMed ID: 19076342
    [Abstract] [Full Text] [Related]

  • 15. Neuron-directed autoimmunity in the central nervous system: entities, mechanisms, diagnostic clues, and therapeutic options.
    Melzer N, Meuth SG, Wiendl H.
    Curr Opin Neurol; 2012 Jun 15; 25(3):341-8. PubMed ID: 22487567
    [Abstract] [Full Text] [Related]

  • 16. Specific central nervous system recruitment of HLA-G(+) regulatory T cells in multiple sclerosis.
    Huang YH, Zozulya AL, Weidenfeller C, Metz I, Buck D, Toyka KV, Brück W, Wiendl H.
    Ann Neurol; 2009 Aug 15; 66(2):171-83. PubMed ID: 19705413
    [Abstract] [Full Text] [Related]

  • 17. [Cerebral lateralization and immune response].
    Neveu PJ.
    Encephale; 1989 Aug 15; 15(4):405-8. PubMed ID: 2680462
    [Abstract] [Full Text] [Related]

  • 18. B cells as therapeutic targets in autoimmune neurological disorders.
    Dalakas MC.
    Nat Clin Pract Neurol; 2008 Oct 15; 4(10):557-67. PubMed ID: 18813230
    [Abstract] [Full Text] [Related]

  • 19. Autoimmunity as an aetiological factor in vitiligo.
    Rezaei N, Gavalas NG, Weetman AP, Kemp EH.
    J Eur Acad Dermatol Venereol; 2007 Aug 15; 21(7):865-76. PubMed ID: 17658994
    [Abstract] [Full Text] [Related]

  • 20. Boosting controlled autoimmunity: a new therapeutic target for CNS disorders.
    del Barco DG, Berlanga J, Penton E, Hardiman O, Montero E.
    Expert Rev Neurother; 2008 May 15; 8(5):819-25. PubMed ID: 18457538
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.